Cloudera
Genomics and Drug Development R&D Platforms
Pages
3
Time to read
6 mins
Publication
Language
English
Pages
3
Time to read
6 mins
Publication
Language
English
This solution brief outlines the integration of genomics in drug development and clinical trials within the biopharmaceutical industry. It emphasizes the significance of utilizing big data to enhance research and development processes. The document details a project undertaken by a leading biopharma client of Cloudera, which aimed to consolidate genomic data from various silos into a unified data lake. This integration was essential for effective genome analysis and to ensure that all new drug developments included a genomic component. The solution involved three phases: data integration, advanced analytics, and machine learning, utilizing Cloudera Enterprise and tools like Trifacta and Hail. The results demonstrated the capability of the next-generation R&D platform to handle vast amounts of data, supporting numerous structured and unstructured data sources. The project aimed to accelerate drug production while maintaining safety and regulatory compliance, showcasing the potential of big data analytics in biopharma.